Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-01-22 @ 9:01 AM
Study NCT ID:
NCT02628704
Status:
WITHDRAWN
Last Update Posted:
2023-01-26
First Post:
2015-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2017-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-02
First Submit QC Date:
None
Study First Post Date:
2015-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-24
Last Update Post Date:
2023-01-26
Last Update Post Date Type:
ACTUAL